fda warning letters glp-1 september 2025 news issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Pharmacovigilance Assessment of Compounded GLP-1

PlexusDx screening identifies these red-flag conditions before therapy initiation

By using both methods, the study potentially minimized common biases associated with observational data, such as confounding by indication and residual confounding

Because it influences metabolism, inflammation, and brain signaling, semaglutide has been called the everything drug in the media

This study was the first to demonstrate ACs efficacy against complement-mediated ALI, suggesting its therapeutic relevance in immune-mediated lung injury

Retail or hospitality employers with a high turnover might prioritize short-term savings, therefore choosing tight prior authorization rules